Published in J Cereb Blood Flow Metab on December 01, 1999
Quantitative evaluation of oxygenation in venous vessels using T2-Relaxation-Under-Spin-Tagging MRI. Magn Reson Med (2008) 2.42
Cerebral hemodynamic changes of mild traumatic brain injury at the acute stage. PLoS One (2015) 2.21
Noninvasive quantification of whole-brain cerebral metabolic rate of oxygen (CMRO2) by MRI. Magn Reson Med (2009) 1.97
Calibration and validation of TRUST MRI for the estimation of cerebral blood oxygenation. Magn Reson Med (2011) 1.40
QUantitative Imaging of eXtraction of oxygen and TIssue consumption (QUIXOTIC) using venular-targeted velocity-selective spin labeling. Magn Reson Med (2011) 1.35
Determination of whole-brain oxygen extraction fractions by fast measurement of blood T(2) in the jugular vein. Magn Reson Med (2010) 1.13
On improving the speed and reliability of T2-relaxation-under-spin-tagging (TRUST) MRI. Magn Reson Med (2011) 1.04
Blood oxygenation level-dependent (BOLD)-based techniques for the quantification of brain hemodynamic and metabolic properties - theoretical models and experimental approaches. NMR Biomed (2012) 1.03
Blood longitudinal (T1) and transverse (T2) relaxation time constants at 11.7 Tesla. MAGMA (2011) 1.00
Feasibility study of myocardial perfusion and oxygenation by noncontrast MRI: comparison with PET study in a canine model. Magn Reson Imaging (2007) 0.99
Flow compensated quantitative susceptibility mapping for venous oxygenation imaging. Magn Reson Med (2013) 0.98
Venous oxygenation mapping using velocity-selective excitation and arterial nulling. Magn Reson Med (2012) 0.93
A noninvasive tumor oxygenation imaging strategy using magnetic resonance imaging of endogenous blood and tissue water. Magn Reson Med (2014) 0.90
Use of spin echo T(2) BOLD in assessment of cerebral misery perfusion at 1.5 T. MAGMA (2001) 0.88
Calibrating the BOLD signal during a motor task using an extended fusion model incorporating DOT, BOLD and ASL data. Neuroimage (2012) 0.87
Dependence of blood T(2) on oxygenation at 7 T: in vitro calibration and in vivo application. Magn Reson Med (2013) 0.84
T1 and T2 values of human neonatal blood at 3 Tesla: Dependence on hematocrit, oxygenation, and temperature. Magn Reson Med (2015) 0.84
Global intravascular and local hyperoxia contrast phase-based blood oxygenation measurements. Neuroimage (2014) 0.82
Repeatability and sensitivity of T2* measurements in patients with head and neck squamous cell carcinoma at 3T. J Magn Reson Imaging (2016) 0.80
Coupling blood flow and neural function in the retina: a model for homeostatic responses to ocular perfusion pressure challenge. Physiol Rep (2013) 0.79
Does acute caffeine ingestion alter brain metabolism in young adults? Neuroimage (2015) 0.79
Improvement of hyperemic myocardial oxygen extraction fraction estimation by a diffusion-prepared sequence. Magn Reson Med (2010) 0.78
Multisite evaluations of a T2 -relaxation-under-spin-tagging (TRUST) MRI technique to measure brain oxygenation. Magn Reson Med (2015) 0.78
Absolute oxygenation metabolism measurements using magnetic resonance imaging. Open Neuroimag J (2011) 0.76
Searching for a truly "iso-metabolic" gas challenge in physiological MRI. J Cereb Blood Flow Metab (2016) 0.76
Noninvasive MRI measurement of the absolute cerebral blood volume-cerebral blood flow relationship during visual stimulation in healthy humans. Magn Reson Med (2013) 0.76
Non-invasive quantification of absolute cerebral blood volume during functional activation applicable to the whole human brain. Magn Reson Med (2014) 0.76
Measurement of parenchymal extravascular R2* and tissue oxygen extraction fraction using multi-echo vascular space occupancy MRI at 7 T. NMR Biomed (2014) 0.76
Correction and optimization of a T2-based approach to map blood oxygenation in small cerebral veins. Magn Reson Med (2015) 0.75
Cerebral Oxygen Saturation in Children With Congenital Heart Disease and Chronic Hypoxemia. Anesth Analg (2017) 0.75
Magnetic resonance imaging reveals slow-down of global cerebral oxygen metabolism in multiple sclerosis. J Cereb Blood Flow Metab (2012) 0.75
MRI-based methods for quantification of the cerebral metabolic rate of oxygen. J Cereb Blood Flow Metab (2016) 0.75
Accounting for the role of hematocrit in between-subject variations of MRI-derived baseline cerebral hemodynamic parameters and functional BOLD responses. Hum Brain Mapp (2017) 0.75
Three-dimensional tracking of axonal projections in the brain by magnetic resonance imaging. Ann Neurol (1999) 17.45
Improved sensitivity of HSQC spectra of exchanging protons at short interscan delays using a new fast HSQC (FHSQC) detection scheme that avoids water saturation. J Magn Reson B (1995) 4.93
Diffusion tensor imaging and axonal tracking in the human brainstem. Neuroimage (2001) 3.58
In vivo three-dimensional reconstruction of rat brain axonal projections by diffusion tensor imaging. Magn Reson Med (1999) 3.02
Quantitative assessment of blood flow, blood volume and blood oxygenation effects in functional magnetic resonance imaging. Nat Med (1998) 2.87
Longitudinal pattern of regional brain volume change differentiates normal aging from MCI. Neurology (2009) 2.84
Asymptomatic Chiari Type I malformations identified on magnetic resonance imaging. J Neurosurg (2000) 2.63
Sensitive NMR detection of cationic-polymer-based gene delivery systems using saturation transfer via proton exchange. J Am Chem Soc (2001) 2.24
Diffusion tensor imaging of the developing mouse brain. Magn Reson Med (2001) 2.20
Multisection proton MR spectroscopic imaging of the brain. Radiology (1993) 2.19
Accurate quantitation of water-amide proton exchange rates using the phase-modulated CLEAN chemical EXchange (CLEANEX-PM) approach with a Fast-HSQC (FHSQC) detection scheme. J Biomol NMR (1998) 2.14
Comparison of the dependence of blood R2 and R2* on oxygen saturation at 1.5 and 4.7 Tesla. Magn Reson Med (2003) 1.95
Absolute quantitation of diffusion constants in human stroke. Stroke (1997) 1.79
Water diffusion and acute stroke. Magn Reson Med (1994) 1.77
Magnetization transfer MRI demonstrates spinal cord abnormalities in adrenomyeloneuropathy. Neurology (2005) 1.77
Fast three dimensional sodium imaging. Magn Reson Med (1997) 1.76
Quantitative proton MR spectroscopic imaging of the human brain. Magn Reson Med (1996) 1.72
Metabolism of human gliomas: assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET. Radiology (1990) 1.65
Randomized study of CODE versus alternating CAV/EP for extensive-stage small-cell lung cancer: an Intergroup Study of the National Cancer Institute of Canada Clinical Trials Group and the Southwest Oncology Group. J Clin Oncol (1999) 1.63
Quantitative characterization of the corticospinal tract at 3T. AJNR Am J Neuroradiol (2006) 1.62
Monitoring thymidine kinase and ganciclovir-induced changes in rat malignant glioma in vivo by nuclear magnetic resonance imaging. Cancer Gene Ther (1998) 1.62
Fast broadband inversion by adiabatic pulses. J Magn Reson (1998) 1.57
Observation of cerebral metabolites in an animal model of acute liver failure in vivo: a 1H and 31P nuclear magnetic resonance study. J Neurochem (1989) 1.56
Proton exchange as a relaxation mechanism for T1 in the rotating frame in native and immobilized protein solutions. Biochem Biophys Res Commun (2001) 1.55
Estrogen replacement therapy and MRI-demonstrated cerebral infarcts, white matter changes, and brain atrophy in older women: the Cardiovascular Health Study. J Am Geriatr Soc (2000) 1.54
Two-compartment exchange model for perfusion quantification using arterial spin tagging. J Cereb Blood Flow Metab (2001) 1.52
Measurement of tissue oxygen extraction ratios from venous blood T(2): increased precision and validation of principle. Magn Reson Med (2001) 1.52
Early detection of irreversible cerebral ischemia in the rat using dispersion of the magnetic resonance imaging relaxation time, T1rho. J Cereb Blood Flow Metab (2000) 1.49
Magnetic resonance imaging of children without sedation: preparation with simulation. J Am Acad Child Adolesc Psychiatry (1997) 1.46
Proton NMR spectroscopy of solvent-saturable resonances: a new approach to study pH effects in situ. Magn Reson Med (1998) 1.43
Serum uric acid and brain ischemia in normal elderly adults. Neurology (2007) 1.39
1H MRS detects polyunsaturated fatty acid accumulation during gene therapy of glioma: implications for the in vivo detection of apoptosis. Nat Med (1999) 1.38
In vivo visualization of human neural pathways by magnetic resonance imaging. Ann Neurol (2000) 1.37
1H NMR visible lipids in the life and death of cells. Trends Biochem Sci (2000) 1.37
Molecular characterization of the gene cluster coxMSL encoding the molybdenum-containing carbon monoxide dehydrogenase of Oligotropha carboxidovorans. J Bacteriol (1995) 1.35
Quantitative 1H nuclear magnetic resonance diffusion spectroscopy of BT4C rat glioma during thymidine kinase-mediated gene therapy in vivo: identification of apoptotic response. Cancer Res (1998) 1.33
Diffusion-negative stroke: a report of two cases. AJNR Am J Neuroradiol (2000) 1.27
Synaptosomal bioenergetics. The role of glycolysis, pyruvate oxidation and responses to hypoglycaemia. Eur J Biochem (1986) 1.27
Functional analysis of aquaporin-1 deficient red cells. The Colton-null phenotype. J Biol Chem (1996) 1.26
A motion correction scheme by twin-echo navigation for diffusion-weighted magnetic resonance imaging with multiple RF echo acquisition. Magn Reson Med (1998) 1.25
Quantitative magnetic resonance imaging assessment of cerebral ischemia in rat using on-resonance T(1) in the rotating frame. Magn Reson Med (1999) 1.23
Diffusion weighting by the trace of the diffusion tensor within a single scan. Magn Reson Med (1995) 1.19
Human skeletal muscle: sodium MR imaging and quantification-potential applications in exercise and disease. Radiology (2000) 1.17
Intracellular volume and apparent diffusion constants of perfused cancer cell cultures, as measured by NMR. Magn Reson Med (1997) 1.17
On the precision of diffusion/perfusion imaging by gradient sensitization. Magn Reson Med (1992) 1.15
Subcellular distribution of phosphagens in isolated perfused rat heart. FEBS Lett (1980) 1.14
Diffusion imaging of human breast. NMR Biomed (1997) 1.13
Quantitative proton MR spectroscopic imaging of normal human cerebellum and brain stem. Magn Reson Med (2001) 1.12
Evaluation of restricted diffusion in cylinders. Phosphocreatine in rabbit leg muscle. J Magn Reson B (1994) 1.11
Choline-containing compounds in human astrocytomas studied by 1H NMR spectroscopy in vivo and in vitro. J Neurochem (1994) 1.11
Separation of intramolecular NOE and exchange peaks in water exchange spectroscopy using spin-echo filters. J Biomol NMR (1996) 1.09
Neural pathways in tactile object recognition. Neurology (1999) 1.09
Functional magnetic resonance imaging in medicine and physiology. Science (1990) 1.08
Single-scan in vivo lactate editing with complete lipid and water suppression by selective multiple-quantum-coherence transfer (Sel-MQC) with application to tumors. J Magn Reson B (1995) 1.07
A weighted least-squares algorithm for estimation and visualization of relative latencies in event-related functional MRI. Magn Reson Med (2000) 1.07
Water exchange filter with improved sensitivity (WEX II) to study solvent-exchangeable protons. Application to the consensus zinc finger peptide CP-1. J Magn Reson B (1996) 1.07
Current opinions for the treatment of syringomyelia and chiari malformations: survey of the Pediatric Section of the American Association of Neurological Surgeons. Pediatr Neurosurg (2000) 1.06
Phase I clinical trial of pyrazoloacridine NSC366140 (PD115934). Clin Cancer Res (1995) 1.05
Orientation-independent diffusion imaging without tensor diagonalization: anisotropy definitions based on physical attributes of the diffusion ellipsoid. J Magn Reson Imaging (1999) 1.05
Short echo time proton MR spectroscopic imaging. J Comput Assist Tomogr (1993) 1.05
Acute stroke: evaluation with serial proton MR spectroscopic imaging. Radiology (1994) 1.04
Noninvasive detection of cerebral hypoperfusion and reversible ischemia from reductions in the magnetic resonance imaging relaxation time, T2. J Cereb Blood Flow Metab (1998) 1.02
Genistein-induced G2-M arrest, p21WAF1 upregulation, and apoptosis in a non-small-cell lung cancer cell line. Nutr Cancer (1998) 1.01
Compartmentation of citrate in relation to the regulation of glycolysis and the mitochondrial transmembrane proton electrochemical potential gradient in isolated perfused rat heart. Biochim Biophys Acta (1982) 1.00
Aminooxyacetic acid inhibits the malate-aspartate shuttle in isolated nerve terminals and prevents the mitochondria from utilizing glycolytic substrates. Biochim Biophys Acta (1987) 1.00
Effect of transit times on quantification of cerebral blood flow by the FAIR T(1)-difference approach. Magn Reson Med (1999) 1.00
Advanced bronchioloalveolar carcinoma: a phase II trial of paclitaxel by 96-hour infusion (SWOG 9714): a Southwest Oncology Group study. Ann Oncol (2005) 0.99
MR diffusion imaging in stroke: review and controversies. Radiographics (1998) 0.98
Diagnostic assessment of brain tumours and non-neoplastic brain disorders in vivo using proton nuclear magnetic resonance spectroscopy and artificial neural networks. J Cancer Res Clin Oncol (1999) 0.96
Inhibition of tumor cell growth by p21WAF1 adenoviral gene transfer in lung cancer. Cancer Gene Ther (1998) 0.95
Neurochemistry of brain lesions determined by spectroscopic imaging in systemic lupus erythematosus. J Rheumatol (1997) 0.94
Comparison of single-shot localization methods (STEAM and PRESS) for in vivo proton NMR spectroscopy. NMR Biomed (1989) 0.94
Proton MR spectroscopy in acute middle cerebral artery stroke. AJNR Am J Neuroradiol (1996) 0.94
Single-shot localized echo-planar imaging (STEAM-EPI) at 4.7 tesla. Magn Reson Med (1990) 0.92
Inverse T(2) contrast at 1.5 Tesla between gray matter and white matter in the occipital lobe of normal adult human brain. Magn Reson Med (2001) 0.92
Automated classification of human brain tumours by neural network analysis using in vivo 1H magnetic resonance spectroscopic metabolite phenotypes. Neuroreport (1996) 0.91
Graded reduction of cerebral blood flow in rat as detected by the nuclear magnetic resonance relaxation time T2: a theoretical and experimental approach. J Cereb Blood Flow Metab (2000) 0.91
Venous blood effects in spin-echo fMRI of human brain. Magn Reson Med (1999) 0.91
Measurement of water-amide proton exchange rates in the denatured state of staphylococcal nuclease by a magnetization transfer technique. Proteins (1997) 0.91
Multislice proton magnetic resonance spectroscopic imaging in X-linked adrenoleukodystrophy. Ann Neurol (1994) 0.91
Broadband adiabatic refocusing without phase distortion. J Magn Reson (1997) 0.91
MR imaging of the human brain at 1.5 T: regional variations in transverse relaxation rates in the cerebral cortex. AJNR Am J Neuroradiol (2001) 0.90
Dissociation of the neural systems for working memory maintenance of verbal and nonspatial visual information. Cogn Affect Behav Neurosci (2001) 0.90
Rapid monitoring of changes in water diffusion coefficients during reversible ischemia in cat and rat brain. Magn Reson Med (1994) 0.90
Interrelations of T(1) and diffusion of water in acute cerebral ischemia of the rat. Magn Reson Med (2000) 0.90
In vivo NMR diffusion spectroscopy: 31P application to phosphorus metabolites in muscle. Magn Reson Med (1990) 0.90
Post-ECT increases in MRI regional T2 relaxation times and their relationship to cognitive side effects: a pilot study. Psychiatry Res (1994) 0.90
Rapid three-dimensional diffusion MRI facilitates the study of acute stroke in mice. Magn Reson Med (2001) 0.90
Correlation of the average water diffusion constant with cerebral blood flow and ischemic damage after transient middle cerebral artery occlusion in cats. J Cereb Blood Flow Metab (1996) 0.89
A phase II study of dacarbazine and cisplatin in combination with outpatient administered interleukin-2 in metastatic malignant melanoma. Cancer (1993) 0.89
Cerebral T1rho relaxation time increases immediately upon global ischemia in the rat independently of blood glucose and anoxic depolarization. Magn Reson Med (2001) 0.89
¹H nuclear magnetic resonance spectroscopy characterisation of metabolic phenotypes in the medulloblastoma of the SMO transgenic mice. Br J Cancer (2010) 0.89
Correction of motional artifacts in diffusion-weighted images using a reference phase map. Magn Reson Med (1995) 0.89